Table 6 Association between s-AP3D1-Ab levels with data from participants in the Sawara Hospital cohort.

From: Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis

Category

Category division

Category division

Sex

Male

Female

Sample No

396

269

s-AP3D1-Ab levels

Average

11,446

12,628

SD

9468

8592

P value (vs. male)

0.022

Obesity

BMI < 25

BMI ≥ 25

Sample No

498

167

s-AP3D1-Ab levels

Average

12,065

11,502

SD

9646

7418

P value (vs. BMI < 25)

0.783

Other disease

DM-

DM+

Sample No

525

140

s-AP3D1-Ab levels

Average

11,777

12,475

SD

9707

6564

P value (vs. DM-)

0.011

Other disease

HT-

HT+

Sample No

239

426

s-AP3D1-Ab levels

Average

10,308

12,830

SD

9547

8777

P value (vs. HT-)

 < 0.0001

Other disease

CVD-

CVD+

Sample No

623

42

s-AP3D1-Ab levels

Average

11,770

14,212

SD

9073

9854

P value (vs. CVD-)

0.098

Other disease

Lipidemia-

Lipidemia+

Sample No

480

185

s-AP3D1-Ab levels

Average

12,352

10,814

SD

9907

6629

P value (vs. lipidemia-)

0.17

Lifestyle

Non-smoker

Smoker

Sample No

346

319

s-AP3D1-Ab levels

Average

11,131

12,785

SD

7370

10,672

P value (vs. non-smoker)

0.06

Lifestyle

Alcohol−

Alcohol+

Sample No

238

427

s-AP3D1-Ab levels

Average

12,529

11,587

SD

8592

9417

P value (vs. alcohol−)

0.064

  1. The participants were divided as follows: sex (male and female), obesity [body mass index (BMI)], presence (+) or absence (−) of DM complications, hypertension (HT), CVD or dyslipidemia, and lifestyle factors (smoking and alcohol intake habits). The s-AP3D1-Ab levels divided into two groups were compared using the Mann–Whitney U test. Sample numbers, averages, and SDs of the counts and the P-values are shown. Significant associations (P < 0.05) are marked in bold font.
Back to article page